NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

The 7.6 months mPFS of the 99 placebos completely destroys the naysayers argument that cherry picking was used to select the patients in the DCVax-L trial. A placebo patients' mPFS of 7.6 months, extrapolated to the 232 treatment patients would not predict that those treatment patients would have an mOS of over 19 months

Have not some of those criticizing the trial taken note of that? Were they not aware of the fact that the mOS of the 131 unmethylated treatment patients in the DCvsx-L trial was almost equal to the mOS of the matched unmethylated GBM patients of the ECAs?